Allegis Investment Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-5,872
Closed -$1.2M 292
2017
Q3
$1.2M Sell
5,872
-1,299
-18% -$302K 0.28% 91
2017
Q2
$1.74M Sell
7,171
-230
-3% -$54K 0.44% 72
2017
Q1
$1.77M Buy
7,401
+424
+6% +$98.7K 0.46% 68
2016
Q4
$1.47M Buy
6,977
+799
+13% +$166K 0.46% 68
2016
Q3
$1.42M Buy
6,178
+10
+0.2% +$2.44K 0.55% 64
2016
Q2
$1.42M Buy
6,168
+2,627
+74% +$606K 0.72% 40
2016
Q1
$949K Buy
3,541
+819
+30% +$234K 0.55% 70
2015
Q4
$851K Buy
+2,722
New +$810K 0.48% 56

Other funds holding AGN

Allegis Investment Advisors's AGN Position: Q4 2017 in Review

Allegis Investment Advisors sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 5,872 shares — an estimated $1.2M sold.

Allegis Investment Advisors first reported a position in AGN in Q4 2015 and held it in 8 quarters. The position peaked at $1.77M in Q1 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Allegis Investment Advisors reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Allegis Investment Advisors sold 5,872 Allergan plc shares in Q4 2017, an estimated $1.2M.
  • Allegis Investment Advisors first reported a position in Allergan plc in Q4 2015 and held it in 8 quarters.
  • Allegis Investment Advisors's Allergan plc position peaked at $1.77M in Q1 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Allegis Investment Advisors's 13F filing for Q4 2017, filed 5 Feb 2018.